Analysis

Public Citizen’s analyses
 

• Factsheet: How the TPP Endangers Access to Affordable Medicines (updated November 2015)

• Memo: TPP vs. Access to Medicines in Developing Countries; TPP Rolls Back “May 10th Agreement” Reforms (updated November 2015)

• Memo: Three Burning Questions about the TPP Transparency Annex and Its Implications for U.S. Health Care (updated November 2015)

• Memo: Ambiguity Leads to Fallacy: Biologics Exclusivity in the Trans-Pacific Partnership (updated November 2015)

• Memo: TPP Transition Periods: Bad Rules Comming Soon in a TPP Country Near You (updated November 2015)

• Public Citizen Analyses of Final Text of TPP IP Chapter Published by WikiLeaks (October 2015)

• Public Citizen Report: Additional Exclusivity for Biologic Drugs in the TPP: A Need or Greed?

• Memo: Three Burning Questions about the Leaked TPP Transparency Annex and Its Implications for U.S. Health Care

• Public Citizen in the Hardvard Human Rights Journal: Freeing Trade at the Expense of Local Crop Markets?: A Look at the Trans-Pacific Partnership’s new Plant-Related Intellectual Property Rights from a Human Rights Perspective
   
• Public Citizen in the Yale Journal of International law: what Is Patentable Under the Trans-Pacific Partnership? (full article)
   
• Investor-State Attacks on Public Interest Policies: Acces to Medicines; ISDA: Enforcer for Big Pharma Wish List: Health at Stake
   
• Public Citizen Analyses of the October 2014 Trans-Pacific Partnership Intellectual Property Chapter Released by WikiLeaks
   
• Comparative Table of Data Exclusivity Provisions in the U.S. Free Trade Agreements and the U.S. Proposal to the Trans-Pacific Partnership (TPP) Agreement  En español
   

• Comparative Table of Patent Linkage Provisions in U.S. Free Trade Agreements and the U.S. Proposal to the Trans-Pacific Partnership (TPP) Agreement 
  En español
   

• Dangers for Access to Medicines in the Trans-Pacific Partnership Agreement: Fact Sheets
  Brunei | Malaysia | New Zealand
  Canada | Vietnam |  Peru
  

  General 1-pager | en Español | in Chinese
   

• Dangers for Access to Medicines in the Trans-Pacific Partnership Agreement: Comparative Analyses of the U.S. IP proposal to the Trans-Pacific FTA and existing laws in TPP countries
  Australia |  Malaysia | Peru | Vietnam
  Chile | Brunei  | New Zealand
   
• Comparative Chart of Pharmaceutical Patent and Data Provisions in the TRIPS Agreement, Free Trade Agreements between Trans-Pacific FTA Negotiating Countries and the U.S. and the U.S. Proposal to the Trans-Pacific FTA (December 2011)
  Chart with NAFTA provisions
   
• Public Citizen Memo: Leaked New Zealand Paper Challenges Past U.S. FTA Models in Trans-Pacific Trade Negotiations, Access to Medicines at Stake (December, 2010)

 

Joint analyses

• Risks of the Trans-Pacific FTA for Access to Medicines: Analysis of the Leaked U.S. Paper on Eliminating Pre-Grant Opposition, Public Citizen; Health Global Access Project; Initiative for Medicines, Access & Knowledge; Third World Network (July 2011)

• Civil Society Comments on the Trans-Pacific Partnership Agreeement, MSF, HAI-Global, Health GAP, KEI, National Legislative Association on Prescription Drug Prices, Oxfam America, Public Citizen, UAEM (May 2011) (link to keionline.org)
   

Further analyses
 

• MSF Issue Briefing 2013: Trading Away Health: The Trans-Pacific Partnership Agreement
   
• Leaked TPP Investment Chapter Presents a Grave Threat to Access to Medicines, Baker, Northeastern University School of Law and Health Global Access Project
  Leesburg Presentation Format

• U.S. Trade-Enhancing Access to Medicines (Access Window) in its proposed TPP IP text is a sham, Baker, Northeastern University School of Law and Health Global Access Project (October, 2011) (link to infojustice.org)
   
• Oxfam America Analysis of the USTR Trade Enhancing Access to Medicines (TEAM) White Paper, Oxfam America
   
• Oxfam Analysis of U.S. Proposals for IP and Pharmaceutical Pricing Provisions in Trans-Pacific Partnership Agreement Negotiations, Oxfam America 
   
• Comments for the Record to the Subcommittee on Trade of the Committee on Ways and Means–Hearing on the Trans-Pacific Partnership Agreement (TPPA), Knowledge Ecology International (link to keionline.org)
   
• Public Interest Analysis of the U.S. TPP Proposal for an IP Chapter, American University Washington College of Law Program on Information Justice and Intellectual Property (PIJIP), et al. (December 2011) (link to infojustice.org)
   
• How the Trans-Pacific Partnership Agreement Threatens Access to Medicines, Médecins Sans Frontières (September, 2011) (link to doctorswithoutborders.org)

 

Analyses of Trans-Pacific FTA and A2M Archive
 

Leaked Trade Negotiation Documents

 

Wikileaks publishes complete IP chapter, October 2015

Wikileaks publishes Annex on Transparency and Procedural Fairness for Pharmaceutical Products and Medical Devices, June 2015

Wikileaks publishes complete IP chapter, October 2014

Wikileaks publishes complete IP chapter, November 2013

US Documents

Leaked TPP text on Copyright Limitations and Exceptions (links to keionline.org) August, 2012

Leaked US Proposed Investment Chapter (Links to citizenstrade.org) June, 2012

Leaked US Proposed TBT Annexes on Medical Devices, Pharmaceutical Products and Cosmetic Products (links to citizenstrade.org), October, 2011

Leaked US Proposed Transparency Text (links to citizenstrade.org), October, 2011

Leaked US Proposed IP Text (links to citizenstrade.org), October, 2011

Leaked US Trans-Pacific FTA Paper on Eliminating Pre-Grant Opposition, July, 2011

Leaked US Proposed IP Text (links to keionline.org), February, 2011

New Zealand Documents

Leaked Proposed Intellectual Property Text, February, 2011

Leaked Paper submitted by New Zealand on IP Proposal, December, 2010

Chile Documents

Leaked Preliminary Intellectual Property Proposals, February, 2011
 

Regulatory Coherence

Leaked Regulatory Coherence Text (links to citizenstrade.org), October, 2011

---

 

 

Follow Public Citizen’s Global Access to Medicines Program on Twitter: @PCMedsAccess

Back to Trans-Pacific Partnership Page